Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
The particle gel immunoassay (PaGIA) test (Biorad, Oberschleissheim, Germany) was performed in patients from 2010 on with suspected HIT (negative predictive value 98%‐99% and positive predictive value 10%‐40%). Before 2010, an Enzyme‐linked Immunosorbent Assay (ELISA) test (Asserachrom (R) HPIA, Stago Deutschland GmbH, Düsseldorf) was performed as a screening test. In patients with a positive screening test, a functional test (heparin‐induced platelet activation test, HIPA) was initiated for further evaluation.
Copyright and License information: ©2018 Wiley Periodicals, Inc.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
